T
IART icon

Tidemark’s Integra LifeSciences IART Stock Holding History

Tidemark’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790 Hold
44
– – ﹤0.01% 765
2026
Q1 		$414 Hold
44
– – ﹤0.01% 784
2025
Q4 		$546 Hold
44
– – ﹤0.01% 622
2025
Q3 		$631 Hold
44
– – ﹤0.01% 654
2025
Q2 		$540 Hold
44
– – ﹤0.01% 670
2025
Q1 		$968 Buy
+44
New +$1.03K ﹤0.01% 650
2024
Q4 		– Sell
-44
Closed -$799 – 650
2024
Q3 		$799 Hold
44
– – ﹤0.01% 582
2024
Q2 		$1.28K Hold
44
– – ﹤0.01% 549
2024
Q1 		$1.56K Hold
44
– – ﹤0.01% 614
2023
Q4 		$1.92K Buy
+44
New +$1.73K ﹤0.01% 597

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Tidemark's IART Position: Q2 2026 in Review

Tidemark held its Integra LifeSciences (IART) position steady in Q2 2026 at 44 shares worth $790. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Tidemark first reported a position in IART in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.92K in Q4 2023. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Tidemark held 44 shares of Integra LifeSciences worth $790 as of Q2 2026.
  • Tidemark left its Integra LifeSciences share count unchanged in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Tidemark's portfolio in Q2 2026, its #765 holding.
  • Tidemark first reported a position in Integra LifeSciences in Q4 2023 and has held it in 10 quarters since.
  • Tidemark's Integra LifeSciences position peaked at $1.92K in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.